APOA1 and autoimmune disease: When comparing women based on positivity/negativity for anti-ApoA-1 and anti-Ac-terAA1 IgG (Tables 2 and 3), no difference was found for comorbidities (with special reference to autoimmune diseases), therapies, and overall maternal adverse outcomes (Supplementary Tables ).